Mario Plebani obtained his medical degree summa cum laude from the Medical School of the University of Padova in Italy and completed residency training and specialization in Laboratory Medicine, and subsequently in Gastroenterology, at the same University.
He is Honorary Professor of Clinical Biochemistry and Clinical Molecular Biology at the School of Medicine of the University of Padova, Honorary Professor at the University of Buenos Aires (Argentina), Facultad de Farmacia y Bioquimica and Adjunct Professor at University of Texas, Medical Branch (Department of Pathology).
Past-President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Editor-in-Chief of Clinical Chemistry and Laboratory Medicine (CCLM) and Co-Editor-in-Chief of Diagnosis (Dx).
President of QILABMED, spin-off of the University of Padova.
He was appointed Dean of the Medical School of the University of Padova between 2016 and 2019, Member of the Management Board of Directors of the University of Padova (2012-2016), Director, Post-graduate School of Clinical Pathology and Clinical Biochemistry (2007-2020) of the Medical School of the University of Padova.
He has published 1550 full papers, more than 900 abstracts and several books and book chapters, with an h-Index (HI) of 132.
Invited speakers at many national and international meetings and conferences such as the AACC annual meetings in 1998, 2005 and 2007-2012, the IFCC/EFCC International Congresses in Florence (1999), Kyoto (2002), the IFCC-EFLM EuroMedLab in Prague (2001), Barcelona (2003), Glasgow (2005), Innsbruck (2009), Berlin (2012) and Milan (2013), Rome (2022), Dubai (2024) and key-note speaker at many national meetings of IFCC member societies, including Australia, UK, Ireland, Spain, Switzerland, Belgium, Finland, Turkey, Chile, Argentina, Uruguay, Perù.
Awards received: 1991-King Prize for achievement and original research in Clinical Enzymology, International Society for Clinical Enzymology (ISE); 2007-AACC Management Sciences Division, Outstanding Contributions to Management Sciences Award; 2008-AACC Award for Outstanding Clinical Laboratory Contributions to Patient Safety; 2011-ACB (UK) International Lecture Award, 2014-IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) Distinguished Award for Laboratory Medicine and Patient Care and 2014-AACC/NACB Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research and the 2014 Canadian Society (CSCC) “Travelling Lecture” Award; 2019- AACC Outstanding Contributions Through Service to the Profession of Clinical Chemistry Award; 2025 Roman Lecture Award by the Australasian Association for Laboratory Medicine.